Year All202620252024202320222021202020192018201720162015201420132012 ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research Mar 27, 2026 ADMA Biologics Addresses Misleading Short-Seller Report Mar 25, 2026 ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative Mar 02, 2026 ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update Feb 25, 2026 ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 Feb 18, 2026 ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update Jan 12, 2026 ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026 Jan 05, 2026
ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research Mar 27, 2026
ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative Mar 02, 2026
ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update Feb 25, 2026
ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 Feb 18, 2026
ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update Jan 12, 2026
